Compass Pathways PLC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
ATAI Life Sciences N.V. reported a reduction in its beneficial ownership of COMPASS Pathways plc to 6.0% following recent open market sales.
NASDAQ
SCHEDULE 13D/A: ATAI Life Sciences Updates Stake in COMPASS Pathways to 7.5%
ATAI Life Sciences N.V. and its subsidiary ATAI Life Sciences AG have filed an Amendment No. 4 to Schedule 13D, disclosing a beneficial ownership of 7.5% in COMPASS Pathways plc as of March 5, 2025.